Community Prevalence of SARS-CoV-2 Among Patients With Influenzalike Illnesses Presenting to a Los Angeles Medical Center in March 2020
- PMID: 32232421
- PMCID: PMC7110920
- DOI: 10.1001/jama.2020.4958
Community Prevalence of SARS-CoV-2 Among Patients With Influenzalike Illnesses Presenting to a Los Angeles Medical Center in March 2020
Abstract
This study characterizes the prevalence of reverse-transcriptase polymerase chain reaction results positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among patients presenting with influenzalike illness who underwent nasopharyngeal swab testing for influenza and respiratory syncytial virus over 4 days in March 2020.
Conflict of interest statement
Figures
Similar articles
-
Universal and Serial Laboratory Testing for SARS-CoV-2 at a Long-Term Care Skilled Nursing Facility for Veterans - Los Angeles, California, 2020.MMWR Morb Mortal Wkly Rep. 2020 May 29;69(21):651-655. doi: 10.15585/mmwr.mm6921e1. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32463809 Free PMC article.
-
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Universal Testing Experience on a Los Angeles Labor and Delivery Unit.Obstet Gynecol. 2020 Aug;136(2):235-236. doi: 10.1097/AOG.0000000000003987. Obstet Gynecol. 2020. PMID: 32433450 No abstract available.
-
Tracking Potential COVID-19 Outbreaks With Influenzalike Symptoms Urgent Care Visits.Pediatrics. 2020 Oct;146(4):e20201798. doi: 10.1542/peds.2020-1798. Epub 2020 Jul 22. Pediatrics. 2020. PMID: 32699069 No abstract available.
-
Testing for SARS-CoV-2 (COVID-19): A General Review.R I Med J (2013). 2020 Sep 4;103(8):20-23. R I Med J (2013). 2020. PMID: 32900007 Review.
-
Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?J Microbiol Immunol Infect. 2020 Aug;53(4):505-512. doi: 10.1016/j.jmii.2020.05.013. Epub 2020 May 23. J Microbiol Immunol Infect. 2020. PMID: 32482366 Free PMC article. Review.
Cited by
-
Time to maximum amplitude of thromboelastography can predict mortality in patients with severe COVID-19: a retrospective observational study.Front Med (Lausanne). 2024 May 2;11:1356283. doi: 10.3389/fmed.2024.1356283. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38756947 Free PMC article.
-
Missing science: A scoping study of COVID-19 epidemiological data in the United States.PLoS One. 2022 Oct 12;17(10):e0248793. doi: 10.1371/journal.pone.0248793. eCollection 2022. PLoS One. 2022. PMID: 36223335 Free PMC article.
-
COVID-19 and preventive strategy.Am J Cardiovasc Dis. 2022 Aug 15;12(4):153-169. eCollection 2022. Am J Cardiovasc Dis. 2022. PMID: 36147788 Free PMC article. Review.
-
The epidemiology and therapeutic options for the COVID-19.Precis Clin Med. 2020 Jun;3(2):71-84. doi: 10.1093/pcmedi/pbaa017. Epub 2020 May 28. Precis Clin Med. 2020. PMID: 35960683 Free PMC article. Review.
-
SARS-COV-2/COVID-19: scenario, epidemiology, adaptive mutations, and environmental factors.Environ Sci Pollut Res Int. 2022 Oct;29(46):69117-69136. doi: 10.1007/s11356-022-22333-0. Epub 2022 Aug 10. Environ Sci Pollut Res Int. 2022. PMID: 35947257 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous

